A protocol for labrador retrievers?
Lane
Richard
R
The Lancet, London NW1 7BY, UK.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage; D000068579:Celecoxib; D052246:Cyclooxygenase 2 Inhibitors / Q000008:administration & dosage; D004283:Dog Diseases / Q000188:drug therapy*; D004285:Dogs / Q000502:physiology; D004318:Doxycycline / Q000008:administration & dosage; D004338:Drug Combinations; D006801:Humans; D009369:Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000662:veterinary*; D011720:Pyrazoles / Q000008:administration & dosage; D012903:Smell / Q000502:physiology; D013449:Sulfonamides / Q000008:administration & dosage; D013629:Tamoxifen / Q000008:administration & dosage
D000900:Anti-Bacterial Agents; D018931:Antineoplastic Agents, Hormonal; D052246:Cyclooxygenase 2 Inhibitors; D004338:Drug Combinations; D011720:Pyrazoles; D013449:Sulfonamides; D013629:Tamoxifen; D000068579:Celecoxib; D004318:Doxycycline